TABLE 5.
Changes in neuropsychological test scores during the study period in the 3 treatment groups1
Treatment group |
P |
||||
Neuropsychological tests | HF (n = 30) | IF (n = 30) | LF (n = 30) | ANOVA | Time × treatment interaction |
MMSE | |||||
Week 0 | 29.07 ± 0.20 | 29.27 ± 0.20 | 29.23 ± 0.22 | 0.76 | 0.522 |
Week 8 | 29.20 ± 0.17 | 29.27 ± 0.18 | 29.20 ± 0.19 | ||
Change | 0.13 ± 0.13 | 0.00 ± 0.10 | −0.03 ± 0.09 | ||
TMT A, s | |||||
Week 0 | 33.87 ± 1.81 | 32.27 ± 1.67 | 33.07 ± 1.75 | 0.81 | <0.0001 |
Week 8 | 25.25 ± 1.45a | 25.58 ± 1.53a | 32.13 ± 1.82b | 0.0035 | |
Change | −8.57 ± 0.38a | −6.67 ± 0.45a | −0.77 ± 1.57b | <0.0001 | |
P (ANOVA) | <0.0001 | <0.0001 | 0.63 | ||
TMT B, s | |||||
Week 0 | 79.23 ± 3.37 | 78.27 ± 3.43 | 77.45 ± 4.17 | 0.94 | <0.0001 |
Week 8 | 62.71 ± 2.80a | 63.99 ± 3.14a | 76.43 ± 4.21b | 0.01 | |
Change | −16.50 ± 0.8a | −14.20 ± 0.49a | −1.10 ± 0.68b | <0.0001 | |
P (ANOVA) | <0.0001 | <0.0001 | 0.12 | ||
VFT, words/60 s | |||||
Week 0 | 24.87 ± 1.08 | 26.13 ± 1.11 | 23.72 ± 1.28 | 0.38 | <0.0001 |
Week 8 | 32.58 ± 1.60a | 29.62 ± 1.35a,b | 25.05 ± 1.44b | 0.002 | |
Change | 7.70 ± 1.09a | 3.57 ± 1.23b | 1.33 ± 0.45b | <0.0001 | |
P (ANOVA) | <0.0001 | 0.007 | 0.01 | ||
z Score | |||||
Week 0 | −0.058 ± 0.10 | 0.083 ± 0.10 | −0.026 ± 0.17 | 0.72 | <0.0001 |
Week 8 | 0.656 ± 0.10a | 0.582 ± 0.10a | 0.063 ± 0.15b | 0.0013 | |
Change | 0.714 ± 0.03a | 0.498 ± 0.05b | 0.089 ± 0.7c | <0.0001 | |
P (ANOVA) | <0.0001 | <0.0001 | 0.19 |
Values are means ± SEs. Differences within groups were analyzed by ANOVA. Differences between groups were analyzed by ANOVA followed by Tukey’s honestly significant difference test. Values within a row not sharing a common superscript letter are significantly different, P < 0.05. HF, high flavanol intake; IF, intermediate flavanol intake; LF, low flavanol intake; MMSE, Mini-Mental State Examination; TMT, Trail Making Test; VFT, Verbal Fluency Test.
Time effect, P = 0.594; treatment effect, P = 0.878.